Janice Troha
Overview
Janice Troha received an average of $1M in total compensation, including $332K in salary, at Nivalis Therapeutics from 2014 to 2017.
Source: SEC filings on April 24, 2018 and March 21, 2016.
Related executives
We found seven more executives who work or worked at Nivalis Therapeutics.
Mitchell Gold
Nivalis Therapeutics
Chief Executive Officer
Stanford Peng
Nivalis Therapeutics
President and Head of Research and Development
Zelanna Goldberg
Nivalis Therapeutics
Chief Medical Officer
Paul Rickey
Nivalis Therapeutics
Chief Financial Officer
Mark Litton
Nivalis Therapeutics
Chief Operating Officer
R Carruthers
Nivalis Therapeutics
Chief Financial Officer
Jon Congleton
Nivalis Therapeutics